Searching map area
Discontinuation of Dasatinib in Patients With Chronic Myeloid Leukemia-CP Who Have Maintained Complete Molecular Remission for Two Years; Dasatinib Stop Trial
? TBD
clinical trial
Nobody has rated this yet. Be the first!
Lists 0
Instance of
References